BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 17, 2009
View Archived Issues
The 'Rights' Stuff: Offering Gains Pharmacyclics $24M
Rebounding from its 2007 troubles with lung cancer drug Xcytrin, Pharmacyclics Inc. has emerged with a retooled management team, a multiproduct pipeline and a rather unusual - at least for biotech - money-raising strategy. (BioWorld Today)
Read More
Amgen to Face Bundling Hits; CMS Rule Tolerable for Others
Read More
Tysabri Sales Stay Strong in a Good Biogen Quarter
Read More
NewCo News: AngioChem Crossing Barriers in Efforts to Heal the Brain
Read More
BDSI's Cancer Pain Film Onsolis Wins FDA OK
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More
Other News To Note
Read More